11:13 AM EDT, 07/02/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were sharply higher late Thursday morning, advancing 2.21% to 1,927.62 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Cellectis ( CLLS ) and biotech firm Evaxion ( EVAX ) , which climbed 14% and 6.9% respectively. They were followed by biotech company BioNTech (BNTX) and biopharmaceutical company DBV Technologies ( DBVT ) , which advanced 4.5% and 4.1% respectively.

The only decliners from continental Europe were telecommunications company Nokia ( NOK ) and medical device maker EDAP (FOCL), which were down 1% and 0.8% respectively.

The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics ( AKTX ) and NuCana ( NCNA ) , which rose 8.6% and 6.6% respectively. They were followed by biotech firm Autolus Therapeutics ( AUTL ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were up 4.8% and 3.7% respectively.

The only decliners from the UK and Ireland were biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and Amarin ( AMRN ) , which were off 1% and 0.3% respectively.